The company was founded by Dr. Ashleigh Kennedy, a neuroscientist from Stanford University, and Dr. Matthew Kennedy, an Ottawa based family physician. Neurovine has developed proprietary deep tech software that leverages data from wearable technology and artificial intelligence to empower patients to take control of their brain recovery and to equip caregivers to support this process.
Neurovine was created out of personal experience and professional need. Co-founders Ashleigh and Matthew, approach the issue of concussion from different perspectives. As an elite athlete, Ashleigh had personal experience with friends and family members suffering from the negative impact of concussions. She focused her schooling on the study of the brain and human performance but felt that the years of research were stuck in the laboratory.
As a physician, Matthew was frustrated that he did not have the tools to help his patients recover from lingering concussions. The problem is that concussions are highly complex injuries that are nearly impossible to measure. They are invisible.
The patient appears the same to their loved ones, work colleagues, and networks surrounding them, and so, they often suffer in silence. They are confused about their recovery process and become socially isolated, dealing with anxiety and depression.
Neurovine is setting out to empower the patient by measuring brain health and optimizing their recovery process. This data collected by Neurovine allows doctors to track improvement, identify triggers and prescribe appropriate treatment in a way that has not yet been possible.
Over the first year, Dr. Kennedy and her team at Neurovine have worked with Canada’s leading experts in the MedTech space, conducted trials in the Digital Health program at the Elizabeth Bruyère Research Institute, and worked with individuals diagnosed with post-concussion syndrome to refine the technology. In a space that has been long neglected by the advancements of technology, Neurovine strives to be a trailblazer in bringing brain health into the hands of Canadians.
